During the first 24 hours of invasion by the malaria-inducing parasite Plasmodium falciparum, red blood cells start to lose their ability to deform and squeeze through tiny blood vessels-one of the hallmarks of the deadly disease that infects nearly 400 million people each year. Now, an international team of researchers led by an MIT professor has demonstrated just why that happens.
The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.
Ohio University College of Osteopathic Medicine researchers find that elderly diabetics in extended-care facilities need improved treatment protocols for diabetes. Current standards of care fail to meet American Diabetes Association standards for outpatient diabetics.
Smokers who have a say in how they quit are more likely to try kicking the habit and are more successful, according to new research at the University of Rochester.
Researchers at the University of Warwick have found that sexual orientation has a real effect on how we perform mental tasks such as navigating with a map in a car but that old age does not discriminate on grounds of sexual orientation and withers all men?s minds alike just ahead of women?s.
African-Americans appear to perceive people with extreme health problems as less productive or valuable according to a study published in the Journal of Clinical Epidemiology.
University of Nottingham experts have joined forces with Canadian biotech company GangaGen Life Sciences Inc to develop new weapons in the fight against food poisoning.
Naprapathy works better on back and neck trouble than recommended and proven effective advice from doctors, according to a new study from Swedish medical university Karolinska Institutet.
Low-birth-weight infants are more likely to survive if born in hospitals having high performing Neonatal Intensive Care Units, revealed by researchers in a recent study.
Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.